Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units

dc.authoridAylanc, Hakan/0000-0002-8907-3809
dc.authoridKiray, Gulunay/0000-0002-9618-9797
dc.authoridDurukan, Ali Hakan/0000-0001-6571-6155
dc.authoridUstun, Nuran/0000-0003-1680-1825
dc.authoridKaratekin, Guner/0000-0001-7112-0323
dc.authoridsahin, suzan/0000-0002-2599-3075
dc.authoridAkyuz Unsal, Ayse Ipek/0000-0001-5260-674X
dc.contributor.authorBas, Ahmet Yagmur
dc.contributor.authorDemirel, Nihal
dc.contributor.authorKoc, Esin
dc.contributor.authorIsik, Dilek Ulubas
dc.contributor.authorHirfanoglu, Ibrahim Murat
dc.contributor.authorTunc, Turan
dc.contributor.authorSari, Fatma Nur
dc.date.accessioned2025-01-27T20:31:30Z
dc.date.available2025-01-27T20:31:30Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground To evaluate the prevalence, risk factors and treatment of retinopathy of prematurity (ROP) in Turkey and to establish screening criteria for this condition. Methods A prospective cohort study (TR-ROP) was performed between 1 April 2016 and 30 April 2017 in 69 neonatal intensive care units (NICUs). Infants with a birth weight (BW)=1500 g or gestational age (GA)<= 32 weeks and those with a BW> 1500 g or GA> 32 weeks with an unstable clinical course were included in the study. Predictors for the development of ROP were determined by logistic regression analyses. Results The TR-ROP study included 6115 infants: 4964 (81%) with a GA <= 32 weeks and 1151 (19%) with a GA>32 weeks. Overall, 27% had any stage of ROP and 6.7% had severe ROP. A lower BW, smaller GA, total days on oxygen, late-onset sepsis, frequency of red blood cell transfusions and relative weight gain were identified as independent risk factors for severe ROP in infants with a BW=1500 g. Of all infants, 414 needed treatment and 395 (95.4%) of the treated infants had a BW <= 1500 g. Sixty-six (16%) of the treated infants did not fulfil the Early Treatment for Retinopathy of Prematurity requirements for treatment. Conclusions Screening of infants with a GA <= 34 weeks or a BW<1700 g appears to be appropriate in Turkey. Monitoring standards of neonatal care and conducting quality improvement projects across the country are recommended to improve neonatal outcomes in Turkish NICUs.
dc.identifier.doi10.1136/bjophthalmol-2017-311789
dc.identifier.endpage1716
dc.identifier.issn0007-1161
dc.identifier.issn1468-2079
dc.identifier.issue12
dc.identifier.pmid29519879
dc.identifier.startpage1711
dc.identifier.urihttps://doi.org/10.1136/bjophthalmol-2017-311789
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23172
dc.identifier.volume102
dc.identifier.wosWOS:000456552200020
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.ispartofBritish Journal of Ophthalmology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectFor-Gestational-Age
dc.subjectBlood-Transfusion
dc.subjectWeight
dc.subjectInfants
dc.titleIncidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units
dc.typeArticle

Dosyalar